韩国血红蛋白变异体对五种常规HbA1c检测方法的影响
该研究以IFCC参考测量程序(LC-MS)为比对标准,评估了五种常规HbA1c检测方法在114例携带血红蛋白变异体的样本中的表现。结果显示,不同方法间「不可接受」结果的比例差异显著,其中Tosoh G8标准模式高达95%,而Roche Tina-quant最低为7%。结论提示实验室需了解本地常见血红蛋白变异体对所用方法的干扰局限,并建议替代的HbA1c定量方法。
要点
- 五种常规HbA1c方法在血红蛋白变异体存在时与IFCC参考方法相比存在不同程度的偏差。
- Tosoh G8标准模式和ADAMS HA-8180的「不可接受」结果比例最高,分别为95%和89%。
- Sebia Capillarys 2和ADAMS HA-8180在部分变异体样本中未能提供结果。
核心结论
- 五种常规HbA1c检测方法在韩国常见血红蛋白变异体患者中与IFCC参考测量程序相比表现出不同程度的偏差。
研究设计与样本
- 研究纳入114例在全血HPLC HbA1c检测中出现警示标志或无结果的样本,经确认血红蛋白变异体后,使用五种常规方法和IFCC参考测量程序(LC-MS)进行HbA1c定量。
主要发现
- 114例样本中常见变异体包括Hb G-Coushatta(n=47)、Queens(n=41)、Ube-4(n=11)、Chad(n=4)、Yamagata(n=4)等,并发现两种新变异体。
- 对照样本中所有HbA1c结果均在IFCC参考测量程序靶值±7%标准内,判为「可接受」。
- 携带变异体样本的「不可接受」结果比例分别为:Capillarys 2为16%、Tina-quant为7%、Variant II Turbo 2.0为51%、G8标准模式为95%、HA-8180为89%。
- Capillarys 2和HA-8180分别在5例和40例变异体样本中未能提供结果。
关键数值与推荐
- 可接受标准为与IFCC参考测量程序靶值偏差在±7%以内。
临床怎么用
- 实验室应了解所用HbA1c方法对本地常见血红蛋白变异体的干扰局限,并建议替代的HbA1c定量方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Quantification of glycated hemoglobin (HbA1c) is a challenge in patients with hemoglobin (Hb) variants. We evaluated the impact of various Hb variants on five routine HbA1c assays by comparing with the IFCC reference measurement procedure (RMP). METHODS: Whole blood samples showing warning flags or no results on routine HPLC HbA1c assays were confirmed for Hb variants and were submitted to HbA1c quantification using Sebia Capillarys 2 Flex Piercing, Roche Tina-quant HbA1c Gen. 2, Bio-Rad Variant II Turbo 2.0, ADAMS HA-8180, Tosoh G8 standard mode, and IFCC RMP using LC-MS. RESULTS: Among 114 samples, the most common variants were Hb G-Coushatta (n=47), Queens (n=41), Ube-4 (n=11), Chad (n=4), Yamagata (n=4), G-His-Tsou (n=2), G-Taipei (n=1), Fort de France (n=1), Hoshida (n=1), and two novel variants (Hb α-globin, HBA 52 Gly>Cys and Hb β-globin, HBB 146 His>Asn). In terms of control samples, all the result of HbA1c were "acceptable", within the criteria of ±7% compared to IFCC RMP target values. However, percentage of "unacceptable" results of samples with Hb variants were 16% for Capillarys 2, 7% for Tina-quant, 51% for Variant II Turbo 2.0, 95% for G8 standard mode, and 89% for HA-8180. The Capillarys 2 and HA-8180 assay did not provide the results in 5 and 40 samples with Hb variants, respectively. CONCLUSIONS: HbA1c results from five routine assays in patients with relatively common Hb variants in Korea showed various degrees of bias compared to those of IFCC RMP. Therefore, laboratories should be aware of the limitation of their methods with respect to interference from Hb variants found commonly in their local population and suggest an alternative HbA1c quantification method.
引用
- Yun YM, Ji M, Ko DH, et al. Hb variants in Korea: effect on HbA1c using five routine methods. Clin Chem Lab Med. 2017. PMID: 28107170. doi:10.1515/cclm-2016-0865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。